Marianne Stanford
External Website:
Research Interests
The research interests of Immunovaccine include the development of a patented DepoVaxTMvaccine adjuvanting platform and vaccines - candidates for use in cancer immunotherapy, infectious disease and animal health.
Selected publications
Berinstein NL, Karkada M, Morse MA, Nemunaitis JJ, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, Macdonald LD, Weir GM, Stanford M.M., Mansour M. First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine. 2012. Aug 3;10:156
Evgin, L., Vaha-Koskela M., Rintoul, J., LeBoeuf F., Falls, T., Barrett J.W., Bell, J.C. and Stanford, M.M. Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity. Molecular Therapy 2010. May;18(5):896-902.
Stanford M.M., Shaban M., Barrett J.W., Werden S.J., Gilbert P., Bondy-Denomy J., MacKenzie L., Graham K.C, Chambers A.F and McFadden G. Myxoma virus oncolysis of primary and metastatic mouse tumours in vivo. Molecular Therapy. 2008 Jan; 16(1): 52-59.
Stanford, M.M., Barrett, J.W, Nazarian S.H, Werden, S., and McFadden G. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells. Journal of Virology (2007) 81(3): 1251-60